---
figid: PMC5881178__40170_2018_175_Fig4_HTML
figtitle: Metabolomic differences associated with Wnt1-initiated tumors
organisms:
- Mus musculus
- Rattus norvegicus
- Mouse mammary tumor virus
- Molva molva
- Betapolyomavirus macacae
- Turdus migratorius
- Homo sapiens
pmcid: PMC5881178
filename: 40170_2018_175_Fig4_HTML.jpg
figlink: /pmc/articles/PMC5881178/figure/Fig4/
number: F4
caption: 'Metabolomic differences associated with Wnt1-initiated tumors. Metabolomics
  revealed significantly different eicosanoid and cysteine-methionine metabolites
  in Wnt1 tumors compared to other transgenic model tumors. a Eicosanoid metabolism.
  Left: the eicosanoid pathway, with colors indicating increased metabolite levels
  compared to at least three other tumor groups (red), decreased levels (green), no
  change (blue), or not detected (black). Right: Graphs of the quantification of eicosanoid
  precursors (AA) and some eicosanoids. Middle line of box plots indicates median
  of sample group. *P < 0.05, Welch’s t test. b Quantification of cysteine-methionine
  metabolism. CDO1 (black) converts cysteine to hypotaurine. *P < 0.05, Welch’s t
  test. Statistical comparisons were made between Wnt1 and every other sample group.
  Abbreviations: COX cyclooxygenase, LOX lysyl oxidase DHGLA dihomo-γ-linolenic acid,
  HETE hydroxyeicosatetraenoic acid, SAM S-adenosyl methionine, SAH S-adenosylhomocysteine,
  THF tetrahydrofolate, Cdo1 cysteine dioxygenase'
papertitle: Metabolomics of oncogene-specific metabolic reprogramming during breast
  cancer.
reftext: Chen Dai, et al. Cancer Metab. 2018;6:5.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.603164
figid_alias: PMC5881178__F4
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
- Rattus norvegicus
redirect_from: /figures/PMC5881178__F4
ndex: 6c7a7403-df0b-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5881178__40170_2018_175_Fig4_HTML.html
  '@type': Dataset
  description: 'Metabolomic differences associated with Wnt1-initiated tumors. Metabolomics
    revealed significantly different eicosanoid and cysteine-methionine metabolites
    in Wnt1 tumors compared to other transgenic model tumors. a Eicosanoid metabolism.
    Left: the eicosanoid pathway, with colors indicating increased metabolite levels
    compared to at least three other tumor groups (red), decreased levels (green),
    no change (blue), or not detected (black). Right: Graphs of the quantification
    of eicosanoid precursors (AA) and some eicosanoids. Middle line of box plots indicates
    median of sample group. *P < 0.05, Welch’s t test. b Quantification of cysteine-methionine
    metabolism. CDO1 (black) converts cysteine to hypotaurine. *P < 0.05, Welch’s
    t test. Statistical comparisons were made between Wnt1 and every other sample
    group. Abbreviations: COX cyclooxygenase, LOX lysyl oxidase DHGLA dihomo-γ-linolenic
    acid, HETE hydroxyeicosatetraenoic acid, SAM S-adenosyl methionine, SAH S-adenosylhomocysteine,
    THF tetrahydrofolate, Cdo1 cysteine dioxygenase'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Lox
  - Cox4i1
  - H2
  - Hbb-b2
  - Neurod1
  - thf
  - Snhg15
  - Acsm3
  - Wnt1
  - Erbb2
  - Neu1
  - Cdo1
  - LOX
  - COX8A
  - CPOX
  - COX5A
  - COX5B
  - COX6C
  - COX7C
  - .na.character
  - COX4I1
  - COX4I2
  - COX6A1
  - COX6A2
  - COX6B1
  - COX6B2
  - COX7A1
  - COX7A2
  - COX7B
  - COX7B2
  - COX8C
  - NEUROD1
  - TUBB4B
  - ACSM3
  - WNT1
  - ERBB2
  - NEU1
  - NEURL1
  - CDO1
  - Prostaglandin
  - Linoleate
  - arachidonate
  - Linoleic Acid
  - DHGLA
  - Prostaglandin H2
  - Arachidonate
  - Thromboxane B2
  - Prostaglandin D2
  - N,N-dimethyl
  - Methionine
  - Cysteine
  - THF
  - Homocysteine
  - Cystathionine
  - Taurine
  - Hypotaurine
  - Choline
  - Glutathlonine
  - CS-TAG
  - SAH
  - tumors
---
